GlobalData on MSN16h
Novo Nordisk and AI-driven Gensaic enter into $354m cardiometabolic dealNovo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback